Technology - Allinky Biopharma

ALLINKY Biopharma
Go to content

Molecular science to discover new therapeutic compounds


Nature regulates biochemical signals using on/off switches, each of which is specific to a given biochemical signal. Allinky follows a similar approach to design molecular switches that act on biochemical signals known to drive cancer and inflammation. Allinky’s switches are small chemical compounds referred to as allosteric inhibitors thanks to the way in which they produce their effects. The design of each switch is unique and it requires several years of challenging R&D activity, both at the computational and chemical levels.

Allinky operates its proprietary technology platform in collaboration with academic/clinical institutions and in partnership with pharmaceutical companies.
Back to content